Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;34(6):414-8.
doi: 10.1007/BF01741753.

Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

G De Sanctis  1 , V Bottari, A Frezzolini, M Ficcardi, G De Rossi, M C Petti, F Mandelli, L Fontana
Affiliations

Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromes

G De Sanctis et al. Cancer Immunol Immunother. 1992.

Abstract

In this study we analysed the in vitro effect of recombinant interferon gamma on cytotoxic activities mediated by both lymphoid and polymorphonuclear cells from 16 patients with myelodysplastic syndromes. Our results indicate the inability of interferon to restore the defective natural killer activity, natural killer cells and lectin-induced cytotoxicity. On the contrary we detected a boosting effect on the depressed polymorphonuclear cell cytotoxic activities. In our view, the ability of interferon to potentiate polymorphonuclear cell lytic efficiency could support an alternative defensive pathway against either neoplastic or infectious agents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Baumann MA, Milson TJ, Patrick CW, Libnock JA, Keller RH. Immunoregulatory abnormalities in myelodysplastic disorders. Am J Hematol. 1986;22:17. - PubMed
    1. Bennet JM, Catovsky D, Daniel MT. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med. 1985;103:626. - PubMed
    1. Beran M, Hansson M, Kiessling R. Human natural killer cells can inhibit clonogenic growth of fresh leukemic cells. Blood. 1983;61:596. - PubMed
    1. Boogaerts MA. Progress in the therapy of myelodysplastic syndromes. Blut. 1989;58:265. - PubMed
    1. Boogaerts MA, Nelissen V, Roelant C, Goossens W. Blood neutrophil functions in primary myelodysplastic syndromes. Br J Haematol. 1983;55:217. - PubMed

MeSH terms

LinkOut - more resources